BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26560447)

  • 1. Interstitial Fluid Flow Increases Hepatocellular Carcinoma Cell Invasion through CXCR4/CXCL12 and MEK/ERK Signaling.
    Shah AD; Bouchard MJ; Shieh AC
    PLoS One; 2015; 10(11):e0142337. PubMed ID: 26560447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interstitial flow in a 3D microenvironment increases glioma invasion by a CXCR4-dependent mechanism.
    Munson JM; Bellamkonda RV; Swartz MA
    Cancer Res; 2013 Mar; 73(5):1536-46. PubMed ID: 23271726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial flow differentially increases patient-derived glioblastoma stem cell invasion via CXCR4, CXCL12, and CD44-mediated mechanisms.
    Kingsmore KM; Logsdon DK; Floyd DH; Peirce SM; Purow BW; Munson JM
    Integr Biol (Camb); 2016 Dec; 8(12):1246-1260. PubMed ID: 27775742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.
    Sutton A; Friand V; Brulé-Donneger S; Chaigneau T; Ziol M; Sainte-Catherine O; Poiré A; Saffar L; Kraemer M; Vassy J; Nahon P; Salzmann JL; Gattegno L; Charnaux N
    Mol Cancer Res; 2007 Jan; 5(1):21-33. PubMed ID: 17259344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
    Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
    J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines.
    Zhang R; Pan X; Huang Z; Weber GF; Zhang G
    PLoS One; 2011; 6(8):e23831. PubMed ID: 21909361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMT Transition Alters Interstitial Fluid Flow-Induced Signaling in ERBB2-Positive Breast Cancer Cells.
    Tchafa AM; Ta M; Reginato MJ; Shieh AC
    Mol Cancer Res; 2015 Apr; 13(4):755-64. PubMed ID: 25566992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway.
    Wang Y; Yu H; Shan Y; Tao C; Wu F; Yu Z; Guo P; Huang J; Li J; Zhu Q; Yu F; Song Q; Shi H; Zhou M; Chen G
    J Exp Clin Cancer Res; 2016 Apr; 35():65. PubMed ID: 27066828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plumbagin Restrains Hepatocellular Carcinoma Angiogenesis by Stromal Cell-Derived Factor (SDF-1)/CXCR4-CXCR7 Axis.
    Zhong J; Li J; Wei J; Huang D; Huo L; Zhao C; Lin Y; Chen W; Wei Y
    Med Sci Monit; 2019 Aug; 25():6110-6119. PubMed ID: 31415486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells.
    Liu H; Pan Z; Li A; Fu S; Lei Y; Sun H; Wu M; Zhou W
    Cell Mol Immunol; 2008 Oct; 5(5):373-8. PubMed ID: 18954561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arg kinase mediates CXCL12/CXCR4-induced invadopodia formation and invasion of glioma cells.
    Chen L; Zhu M; Yu S; Hai L; Zhang L; Zhang C; Zhao P; Zhou H; Wang S; Yang X
    Exp Cell Res; 2020 Apr; 389(1):111893. PubMed ID: 32035133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling.
    Lin Y; Ma Q; Li L; Wang H
    Biochem Cell Biol; 2018 Oct; 96(5):619-626. PubMed ID: 29316404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCF12 promotes the tumorigenesis and metastasis of hepatocellular carcinoma via upregulation of CXCR4 expression.
    Yang J; Zhang L; Jiang Z; Ge C; Zhao F; Jiang J; Tian H; Chen T; Xie H; Cui Y; Yao M; Li H; Li J
    Theranostics; 2019; 9(20):5810-5827. PubMed ID: 31534521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4.
    Schimanski CC; Bahre R; Gockel I; Müller A; Frerichs K; Hörner V; Teufel A; Simiantonaki N; Biesterfeld S; Wehler T; Schuler M; Achenbach T; Junginger T; Galle PR; Moehler M
    Br J Cancer; 2006 Jul; 95(2):210-7. PubMed ID: 16819541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway.
    Yang N; Chen T; Wang L; Liu R; Niu Y; Sun L; Yao B; Wang Y; Yang W; Liu Q; Tu K; Liu Z
    Theranostics; 2020; 10(13):5790-5801. PubMed ID: 32483419
    [No Abstract]   [Full Text] [Related]  

  • 16. NR2F1 contributes to cancer cell dormancy, invasion and metastasis of salivary adenoid cystic carcinoma by activating CXCL12/CXCR4 pathway.
    Gao XL; Zheng M; Wang HF; Dai LL; Yu XH; Yang X; Pang X; Li L; Zhang M; Wang SS; Wu JB; Tang YJ; Liang XH; Tang YL
    BMC Cancer; 2019 Jul; 19(1):743. PubMed ID: 31357956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the CXCL12/CXCR4 axis in milky spots of rats bearing ascitic-type hepatoma.
    Abe H; Ina K; Kitamura H; Sumiyoshi H; Tatsukawa S; Yoshioka H; Fujikura Y
    Anat Sci Int; 2009 Sep; 84(3):226-36. PubMed ID: 19340530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of stromal cell-derived factor-1 (SDF-1) and CXCR4 ligand receptor system in hepatocellular carcinoma.
    Li W; Gomez E; Zhang Z
    J Exp Clin Cancer Res; 2007 Dec; 26(4):527-33. PubMed ID: 18365549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention.
    Zheng N; Chen J; Li T; Liu W; Liu J; Chen H; Wang J; Jia L
    Mol Carcinog; 2017 Aug; 56(8):1896-1908. PubMed ID: 28277622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRaf and MEK inhibitors differentially regulate cell fate and microenvironment in human hepatocellular carcinoma.
    Breunig C; Mueller BJ; Umansky L; Wahl K; Hoffmann K; Lehner F; Manns MP; Bantel H; Falk CS
    Clin Cancer Res; 2014 May; 20(9):2410-23. PubMed ID: 24573550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.